JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linck, B.
Right arrow Articles by Neumann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linck, B.
Right arrow Articles by Neumann, J.

Vol. 286, Issue 1, 531-538, July 1998

Long-term Beta Adrenoceptor-Mediated Alteration in Contractility and Expression of Phospholamban and Sarcoplasmic Reticulum Ca++-ATPase in Mammalian Ventricle1

Bettina Linck, Peter Bokník, Hideo A. Baba, Thomas Eschenhagen, Uta Haverkamp, Elmar Jäckel, Larry R. Jones, Uwe Kirchhefer, Jörg Knapp, Stephanie Läer, Frank U. Müller, Wilhelm Schmitz, Hasso Scholz, Annemarie Syska, Ute Vahlensieck and Joachim Neumann

Institut für Pharmakologie und Toxikologie der Westfälischen Wilhelms-Universität, Domagkstrabeta e 12, D-48149 Münster, Germany (B.L., P.B., U.H., U.K., J.K., F.U.M., W.S., A.S., U.V., J.N.); Institut für Pathologie der Westfälischen Wilhelms-Universität, Domagkstrabeta e 17, D-48149 Münster, Germany (H.A.B.); Abteilung Allgemeine Pharmakologie, Universitäts-Krankenhaus Eppendorf, Martinistrabeta e 52, D-20246 Hamburg, Germany (T.E., E.J., S.L., H.S); and Department of Medicine and Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, Indiana (L.R.J.)

We studied the influence of prolonged administration of the beta adrenoceptor agonist isoproterenol on contractile parameters and expression of sarcoplasmic reticulum (SR) Ca++-ATPase and phospholamban, genes important for Ca++ uptake into the SR. Isoproterenol (Iso), 0.9% NaCl (Ctr), propranolol (Prop) or Iso plus Prop were administered to rats by subcutaneous infusion with osmotic minipumps for 1, 2, 3, 4, 8, 13 and 26 days, respectively. The positive inotropic effect of Iso was impaired in rats pretreated with Iso in vivo. Iso pretreatment shortened time to peak tension (TPT) by 28%, time of relaxation (RT) by 27% and total contraction time (TCT) by 27% compared with the appropriate controls (day 2). The shortening of time-dependent contractile indices started after 1 day of Iso pretreatment, reached a maximum after 2 days and remained reduced for 4 days. Longer treatment by Iso failed to affect time parameters, whereas the positive inotropic effect of Iso added to the isolated muscles persisted. The shortened contractile time parameters were accompanied by diminished mRNA and protein expression of phospholamban (PLB) and SR-Ca++-ATPase (SERCA). The mRNA levels for PLB and SERCA were maximally reduced by 31 ± 1.3% and 41 ± 1.4% in the Iso-pretreated group (2 days) respectively. The reduced mRNA levels were accompanied by reduced levels of the corresponding proteins. It is concluded that altered levels of PLB and SERCA probably account for the noted changes in contractile time parameters in the mammalian heart.

0022-3565/98/2861-0531$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Eur Heart JHome page
H. M. Nef, H. Mollmann, C. Troidl, S. Kostin, S. Voss, P. Hilpert, C. B. Behrens, A. Rolf, J. Rixe, M. Weber, et al.
Abnormalities in intracellular Ca2+ regulation contribute to the pathomechanism of Tako-Tsubo cardiomyopathy
Eur. Heart J., June 13, 2009; (2009) ehp240v1.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
P. Krenek, J. Kmecova, D. Kucerova, Z. Bajuszova, P. Musil, A. Gazova, P. Ochodnicky, J. Klimas, and J. Kyselovic
Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function
Eur J Heart Fail, February 1, 2009; 11(2): 140 - 146.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Vanderheyden, W. Mullens, L. Delrue, M. Goethals, B. de Bruyne, W. Wijns, P. Geelen, S. Verstreken, F. Wellens, and J. Bartunek
Myocardial Gene Expression in Heart Failure Patients Treated With Cardiac Resynchronization Therapy: Responders Versus Nonresponders
J. Am. Coll. Cardiol., January 15, 2008; 51(2): 129 - 136.
[Abstract] [Full Text] [PDF]

Home page
 J CARDIOVASC PHARMACOL THERHome page
N. S. Dhalla, M. R. Dent, P. S. Tappia, R. Sethi, J. Barta, and R. K. Goyal
Subcellular Remodeling as a Viable Target for the Treatment of Congestive Heart Failure
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2006; 11(1): 31 - 45.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. W. Rodenbaugh, H. L. Collins, D. G. Nowacek, and S. E. DiCarlo
Increased susceptibility to ventricular arrhythmias is associated with changes in Ca2+ regulatory proteins in paraplegic rats
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2605 - H2613.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
O. Zolk, M. Marx, E. Jackel, A. El-Armouche, and T. Eschenhagen
{beta}-Adrenergic stimulation induces cardiac ankyrin repeat protein expression: involvement of protein kinase A and calmodulin-dependent kinase
Cardiovasc Res, September 1, 2003; 59(3): 563 - 572.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
B. D. Lowes, E. M. Gilbert, W. T. Abraham, W. A. Minobe, P. Larrabee, D. Ferguson, E. E. Wolfel, J. Lindenfeld, T. Tsvetkova, A. D. Robertson, et al.
Myocardial Gene Expression in Dilated Cardiomyopathy Treated with Beta-Blocking Agents
N. Engl. J. Med., May 2, 2002; 346(18): 1357 - 1365.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
P. Boknik, I. Heinroth-Hoffmann, U. Kirchhefer, J. Knapp, B. Linck, H. Luss, T. Muller, W. Schmitz, O.-E. Brodde, and J. Neumann
Enhanced protein phosphorylation in hypertensive hypertrophy
Cardiovasc Res, September 1, 2001; 51(4): 717 - 728.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Mirit, C. Gross, Y. Hasin, A. Palmon, and M. Horowitz
Changes in cardiac mechanics with heat acclimation: adrenergic signaling and SR-Ca regulatory proteins
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2000; 279(1): R77 - R85.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
P. Boknik, C. Unkel, U. Kirchhefer, U. Kleideiter, O. Klein-Wiele, J. Knapp, B. Linck, H. Luss, F. Ulrich Muller, W. Schmitz, et al.
Regional expression of phospholamban in the human heart
Cardiovasc Res, July 1, 1999; 43(1): 67 - 76.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.